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memory consolidation and (fast) NREM sleep spindle change
indicating a beneficial cognitive effect of the SMR training protocol.
Conclusion: Current results indicate that besides healthy individu-
als also people suffering from primary insomnia can benefit subjec-
tively as well as objectively from SMR conditioning.
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Objectives: Sleep Restriction Therapy (SRT) is a highly utilised and
effective Cognitive Behavioural Therapy for Insomnia. However, little
is known about how and when this intervention may work. In this
study, the Daytime Insomnia Symptom Scale (DISS) was employed
within an Ecological Momentary Assessment (EMA) technique to
examine the daytime impact before (1 week) and during SRT
(3 weeks) at four time points per day.
Method: Nine participants (six females; mean age = 46.4) highly
screened for Psychophysiological Insomnia completed paper-based
versions of the DISS at Risetime, Noon, 18:00, and Bedtime, for
1 week before the intervention (Baseline) and for 3 weeks during the
intervention (Weeks: 1, 2, and 3).
Results: Insomnia Severity Index scores were found to significantly
decrease pre-to-post treatment [M = 18 (5) versus 7 (5), P < 0.05].
The completion rate for the DISS was high at 94.62%. Four
previously validated factors from the DISS were examined; Alert
Cognition, Positive Mood, Negative Mood, and Sleepiness/Fatigue. A
mixed model analysis was implemented for each of the factors (fixed
effects for week and time of day, and random effects for between
subject variation).
Alert Cognition initially decreased (P < 0.05) compared to Baseline at
Week 1, subsequently returning to Baseline levels by Week 3 of
SRT. Within the Day Time points; Alert Cognition reduced at Bedtime
and increased at Risetime by Week 3 compared to Baseline.
Negative Mood remained stable across the weeks.
Positive Mood initially decreased compared to Baseline at Week 1
(P < 0.05). At Week 2, scores returned to Baseline levels, and by
Week 3 scores generally increased compared to Baseline (P = 0.06).
Sleepiness/Fatigue initially increased at Week 1 compared to
Baseline (P < 0.001). Scores then slightly reduced at Week 2
compared to Baseline (P = 0.143). At Week 3 scores significantly
decreased compared to Baseline (P < 0.001).
Conclusion: This study represents the first attempt to profile the
daytime experience of insomnia during SRT, via EMA methods.
Changes at Risetime and Bedtime for Alert Cognition and Sleepi-
ness/Fatigue seem like candidates for further study as mechanisms
of action in SRT treatment response; potentially reflecting changes to
the input and output of the sleep homeostat. This study demonstrates
the value of assessing symptoms at multiple time-points throughout
insomnia treatment.
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Objective: This study investigated group delivery of a mindfulness-
based intervention for primary insomnia in an Australian population.
Mindfulness Based Therapy for Insomnia (MBT-I) offers an alterna-
tive approach to the current gold standard, non-pharmacological
approach to insomnia, CBT-I, with a focus on reducing sleep-related
arousal. Findings have indicated reductions in several subjective
sleep measures following MBT-I treatment (Ong, Shapiro, & Manber,
2008). This study aimed to investigate the outcome of MBT-I in an
Australian population recruited from a sleep clinic to examine the
generalizability in a diverse sample. Participants: 30 participants,
consisting of 21 females (M age = 50, range = 26–72) and nine
males (M age = 45, range 34–59) who met criteria for primary
insomnia.
Methods: Treatment consisted of six sessions of MBT-I (Ong,
Shapiro, & Manber, 2008) delivered in groups of 7–8 with each
session lasting 2 h in duration. The primary outcome measure was
the Insomnia Severity Index (ISI) and secondary the Pittsburg Sleep
Quality Index (PSQI). Outcome measures were recorded at four time-
points (screening, baseline, post-treatment and 3 month follow-up).
Results: The average severity of insomnia as measured by the ISI
reduced significantly from a moderate level of insomnia (M = 18.74)
to sub-clinical insomnia (M = 12.79, P < 0.01) indicating that on
average, participants no longer met the criteria for insomnia following
treatment. The Pittsburgh Sleep Quality Index (PSQI) overall score
reduced significantly (M = 13.1 to M = 9.2, P < 0.01) reflecting an
increase in sleep quality following treatment. All 7 PSQI component
scores reduced significantly. The largest change was the component
score assessing sleep efficiency (the proportion of average sleep
compared to time in bed), which increased from 72% to 83%
(P < 0.01) following treatment.
Conclusion: Analysis of data collected in response to a group
treatment of MBT-I for insomnia delivered over 6 weeks revealed
significant reductions in insomnia symptoms, and improvements in
sleep quality and sleep efficiency. This suggests that MBT-I can be
delivered in a sleep clinic setting with indications of effectiveness.
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Sleepiness is one of the most causes of road accidents and may be
linked to sleep disorders, circadian problem or hypnotic consumption.
Among sleep disorders, insomnia is one of the most prevalent sleep
complain as it reaches about 30% of general population. Although
epidemiological studies have showed that sleepiness increases the
risk of driving accidents, the effects of insomnia on driving perfor-
mance are unknown. The purpose of this work was thus to assess
the driving performance of untreated insomniac patients.
To date, twenty insomniacs and 15 good sleepers matched in age
and sex were recruited. Monotonous driving performance was
evaluated with a mono-screen driving simulator. Subjects had to
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